ImportantTMO
Explain this story: Thermo Fisher Scientific (TMO) Adds New Separation Platform To Its Proteomics Toolkit
Explain like I'm 7
Thermo Fisher is adding another company's science tool to its own lab machines. This helps scientists tiny proteins better.
Partnership · Reseller agreement to add Evosep's Eno platformSimply Wall StreetSector and industry: HealthcareDiagnostics & ResearchTell me moreShow less
Explain like I'm 7
Thermo Fisher is adding another company's science tool to its own lab machines. This helps scientists tiny proteins better.
What happenedFrom the article
- Thermo Fisher signed a reseller agreement with Evosep.
- The deal integrates Evosep's Eno separation platform into Thermo Fisher's mass spectrometry lineup.
- This supports Thermo Fisher's strategy of offering an 'end-to-end' toolkit for biopharma workflows.
- The summary notes potential pressures from relying on a third-party platform and revenue-sharing terms.
Why investors careOur explanation
Adding a partner's technology can make a company's product lineup more complete, which can encourage customers to stick with one supplier for more of their needs. But sharing